<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39465865</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>41</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>11</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Causal relationship and mediation effects of immune cells and plasma metabolites in atopic dermatitis: A Mendelian randomization study.</ArticleTitle><Pagination><StartPage>e39932</StartPage><MedlinePgn>e39932</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e39932</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000039932</ELocationID><Abstract><AbstractText>Atopic dermatitis (AD) is a chronic inflammatory skin condition with complex etiology involving genetic, environmental, and immunological factors. This study employs Mendelian randomization to explore the causal relationships between immune cell phenotypes and AD, and the mediating effects of plasma metabolites. Using data from European cohorts, we identified 7 immune cell phenotypes significantly associated with AD. Mediation analysis revealed that the alpha-ketobutyrate to 4-methyl-2-oxopentanoate ratio negatively regulates CCR2 on monocytes, while the glycerol to carnitine ratio positively regulates HLA-DR on CD14- CD16- cells. These findings underscore the critical role of metabolic pathways in modulating immune responses and suggest potential dietary and therapeutic interventions for AD management. Further research should consider more diverse populations to validate these findings.</AbstractText><CopyrightInformation>Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Kaiwen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Basic Medicine, Southwest Medical University, Luzhou, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Jianqiao</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Xian</LastName><ForeName>Dehai</ForeName><Initials>D</Initials><Identifier Source="ORCID">0009-0000-6441-8447</Identifier></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2023XGZX001</GrantID><Agency>Based on the extraction of SARS-CoV-2 infected body organ tissues construction of Basic Human Tissue Resource Library</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054390">Receptors, CCR2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C515334">CCR2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018950">Lipopolysaccharide Receptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006684">HLA-DR Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>S7UI8SM58A</RegistryNumber><NameOfSubstance UI="D002331">Carnitine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000632510">CD14 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C428200">FCGR3B protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017452">Receptors, IgG</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058851">GPI-Linked Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003876" MajorTopicYN="Y">Dermatitis, Atopic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="Y">Mendelian Randomization Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054390" MajorTopicYN="N">Receptors, CCR2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018950" MajorTopicYN="N">Lipopolysaccharide Receptors</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006684" MajorTopicYN="N">HLA-DR Antigens</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002331" MajorTopicYN="N">Carnitine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000081983" MajorTopicYN="N">Mediation Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017452" MajorTopicYN="N">Receptors, IgG</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058851" MajorTopicYN="N">GPI-Linked Proteins</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>8</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39465865</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000039932</ArticleId><ArticleId IdType="pii">00005792-202410110-00083</ArticleId><ArticleId IdType="pmc">PMC11479512</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sroka-Tomaszewska J, Trzeciak M. Molecular mechanisms of atopic dermatitis pathogenesis. Int J Mol Sci. 2021;22:4130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8074061</ArticleId><ArticleId IdType="pubmed">33923629</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres T, Ferreira EO, Gonçalo M, Mendes-Bastos P, Selores M, Filipe P. Update on atopic dermatitis. Acta Med Port. 2019;32:606–13.</Citation><ArticleIdList><ArticleId IdType="pubmed">31493365</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y, Zhang L, Chen Y, Wang H, Xie J. Gut microbiota and atopic dermatitis: a two-sample Mendelian randomization study. Front Med (Lausanne). 2023;10:1174331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10323683</ArticleId><ArticleId IdType="pubmed">37425302</ArticleId></ArticleIdList></Reference><Reference><Citation>Bylund S, Kobyletzki LB, Svalstedt M, Svensson A. Prevalence and incidence of atopic dermatitis: a systematic review. Acta Derm Venereol. 2020;100:adv00160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9189744</ArticleId><ArticleId IdType="pubmed">32412646</ArticleId></ArticleIdList></Reference><Reference><Citation>Amerio P, Ferrucci SM, Galluzzo M, et al. . A multidisciplinary approach is beneficial in atopic dermatitis. Dermatol Ther (Heidelb). 2024;14:1443–55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11169114</ArticleId><ArticleId IdType="pubmed">38811470</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HO. Targeting cytokines and signaling molecules related to immune pathways in atopic dermatitis: therapeutic implications and challenges. Arch Pharm Res. 2022;45:894–908.</Citation><ArticleIdList><ArticleId IdType="pubmed">36462097</ArticleId></ArticleIdList></Reference><Reference><Citation>David E, Ungar B, Renert-Yuval Y, Facheris P, Del Duca E, Guttman-Yassky E. The evolving landscape of biologic therapies for atopic dermatitis: Present and future perspective. Clin Exp Allergy. 2023;53:156–72.</Citation><ArticleIdList><ArticleId IdType="pubmed">36653940</ArticleId></ArticleIdList></Reference><Reference><Citation>Suárez-Fariñas M, Dhingra N, Gittler J, et al. . Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol. 2013;132:361–70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3991240</ArticleId><ArticleId IdType="pubmed">23777851</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zhu Z. Role of Ubiquitin-conjugating enzyme E2 (UBE2) in two immune-mediated inflammatory skin diseases: a Mendelian randomization analysis. Arch Dermatol Res. 2024;316:249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11127807</ArticleId><ArticleId IdType="pubmed">38795139</ArticleId></ArticleIdList></Reference><Reference><Citation>Fassett MS, Braz JM, Castellanos CA, et al. . IL-31-dependent neurogenic inflammation restrains cutaneous type 2 immune response in allergic dermatitis. Sci Immunol. 2023;8:eabi6887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10890830</ArticleId><ArticleId IdType="pubmed">37831760</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestergaard C, Just H, Baumgartner Nielsen J, Thestrup-Pedersen K, Deleuran M. Expression of CCR2 on monocytes and macrophages in chronically inflamed skin in atopic dermatitis and psoriasis. Acta Derm Venereol. 2004;84:353–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15370700</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramovits W. Atopic dermatitis. J Am Acad Dermatol. 2005;53(1 Suppl 1):S86–93.</Citation><ArticleIdList><ArticleId IdType="pubmed">15968268</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi HL, Yamaguchi Y, Peeva E. Role of innate immunity in allergic contact dermatitis: an update. Int J Mol Sci. 2023;24:12975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10455292</ArticleId><ArticleId IdType="pubmed">37629154</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng F, Qiu Y, Zhang X, et al. . GB12-09, a bispecific antibody targeting IL4Rα and IL31Rα for atopic dermatitis therapy. Antib Ther. 2024;7:77–87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10873276</ArticleId><ArticleId IdType="pubmed">38371956</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmi-Levy I, Homey B, Soumelis V. A modular view of cytokine networks in atopic dermatitis. Clin Rev Allergy Immunol. 2011;41:245–53.</Citation><ArticleIdList><ArticleId IdType="pubmed">21222175</ArticleId></ArticleIdList></Reference><Reference><Citation>Humeau M, Boniface K, Bodet C. Cytokine-mediated crosstalk between keratinocytes and T cells in atopic dermatitis. Front Immunol. 2022;13:801579.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9022745</ArticleId><ArticleId IdType="pubmed">35464457</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a review. Res Synth Methods. 2019;10:486–96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6973275</ArticleId><ArticleId IdType="pubmed">30861319</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekula P, Del Greco MF, Pattaro C, Köttgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol. 2016;27:3253–65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5084898</ArticleId><ArticleId IdType="pubmed">27486138</ArticleId></ArticleIdList></Reference><Reference><Citation>Orrù V, Steri M, Sidore C, et al. . Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52:1036–45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8517961</ArticleId><ArticleId IdType="pubmed">32929287</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Lu T, Pettersson-Kymmer U, et al. . Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat Genet. 2023;55:44–53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7614162</ArticleId><ArticleId IdType="pubmed">36635386</ArticleId></ArticleIdList></Reference><Reference><Citation>Sliz E, Huilaja L, Pasanen A, et al. . FinnGen; Estonian Biobank Research Team. Uniting biobank resources reveals novel genetic pathways modulating susceptibility for atopic dermatitis. J Allergy Clin Immunol. 2022;149:1105–12.e9.</Citation><ArticleIdList><ArticleId IdType="pubmed">34454985</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Huang H, Liu Z, et al. . The associations between modifiable risk factors and nonalcoholic fatty liver disease: a comprehensive Mendelian randomization study. Hepatology. 2023;77:949–64.</Citation><ArticleIdList><ArticleId IdType="pubmed">35971878</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamat MA, Blackshaw JA, Young R, et al. . PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics. 2019;35:4851–3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6853652</ArticleId><ArticleId IdType="pubmed">31233103</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13:e1007081. Erratum in: PLoS Genet. 2017 Dec 29;13(12):e1007149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5711033</ArticleId><ArticleId IdType="pubmed">29149188</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Thompson SG; CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40:755–64.</Citation><ArticleIdList><ArticleId IdType="pubmed">21414999</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658–65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4377079</ArticleId><ArticleId IdType="pubmed">24114802</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693–8. Erratum in: Nat Genet. 2018 Aug;50(8):1196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6083837</ArticleId><ArticleId IdType="pubmed">29686387</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkatzionis A, Burgess S, Newcombe PJ. Statistical methods for cis-Mendelian randomization with two-sample summary-level data. Genet Epidemiol. 2023;47:3–25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7614127</ArticleId><ArticleId IdType="pubmed">36273411</ArticleId></ArticleIdList></Reference><Reference><Citation>Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354:610–21.</Citation><ArticleIdList><ArticleId IdType="pubmed">16467548</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Yao J, Tu T, Yao B, Zhang J. Heterotrophic and autotrophic production of L-isoleucine and L-valine by engineered Cupriavidus necator H16. Bioresour Technol. 2024;398:130538.</Citation><ArticleIdList><ArticleId IdType="pubmed">38452952</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Zhang Y, Guo X, et al. . Isoleucine biosynthesis in Leptospira interrogans serotype lai strain 56601 proceeds via a threonine-independent pathway. J Bacteriol. 2004;186:5400–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC490871</ArticleId><ArticleId IdType="pubmed">15292141</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G. Amino acids: metabolism, functions, and nutrition. Amino Acids. 2009;37:1–17.</Citation><ArticleIdList><ArticleId IdType="pubmed">19301095</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Chu Z, Liu M, et al. . Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy. J Hematol Oncol. 2023;16:59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10240810</ArticleId><ArticleId IdType="pubmed">37277776</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch CJ, Adams SH. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol. 2014;10:723–36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4424797</ArticleId><ArticleId IdType="pubmed">25287287</ArticleId></ArticleIdList></Reference><Reference><Citation>Houtkooper RH, Cantó C, Wanders RJ, Auwerx J. The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev. 2010;31:194–223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2852209</ArticleId><ArticleId IdType="pubmed">20007326</ArticleId></ArticleIdList></Reference><Reference><Citation>Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274–93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3331679</ArticleId><ArticleId IdType="pubmed">22500797</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387:1109–22.</Citation><ArticleIdList><ArticleId IdType="pubmed">26377142</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Auria E, Banderali G, Barberi S, et al. . Atopic dermatitis: recent insight on pathogenesis and novel therapeutic target. Asian Pac J Allergy Immunol. 2016;34:98–108.</Citation><ArticleIdList><ArticleId IdType="pubmed">27007830</ArticleId></ArticleIdList></Reference><Reference><Citation>Kader HA, Azeem M, Jwayed SA, et al. . Current insights into immunology and novel therapeutics of atopic dermatitis. Cells. 2021;10:1392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8226506</ArticleId><ArticleId IdType="pubmed">34200009</ArticleId></ArticleIdList></Reference><Reference><Citation>Savolainen J, Kosonen J, Kortekangas-Savolainen O, Yssel H, Bousquet J. HLA-DR-dependent increased mannan-induced lymphoproliferative response in atopic eczema dermatitis syndrome. Allergy. 2003;58:72–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12580811</ArticleId></ArticleIdList></Reference><Reference><Citation>Piletta PA, Wirth S, Hommel L, Saurat JH, Hauser C. Circulating skin-homing T cells in atopic dermatitis. Selective up-regulation of HLA-DR, interleukin-2R, and CD30 and decrease after combined UV-A and UV-B phototherapy. Arch Dermatol. 1996;132:1171–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8859027</ArticleId></ArticleIdList></Reference><Reference><Citation>Spector AA, Kim HY. Discovery of essential fatty acids. J Lipid Res. 2015;56:11–21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4274059</ArticleId><ArticleId IdType="pubmed">25339684</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder PC. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids. 2008;79:101–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18951005</ArticleId></ArticleIdList></Reference><Reference><Citation>Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029–33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2849637</ArticleId><ArticleId IdType="pubmed">19460998</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest. 2018;128:2657–69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6025982</ArticleId><ArticleId IdType="pubmed">29757195</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimomura Y, Murakami T, Nakai N, Nagasaki M, Harris RA. Exercise promotes BCAA catabolism: effects of BCAA supplementation on skeletal muscle during exercise. J Nutr. 2004;134(6 Suppl):1583S–7S.</Citation><ArticleIdList><ArticleId IdType="pubmed">15173434</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper AE, Miller RH, Block KP. Branched-chain amino acid metabolism. Annu Rev Nutr. 1984;4:409–54.</Citation><ArticleIdList><ArticleId IdType="pubmed">6380539</ArticleId></ArticleIdList></Reference><Reference><Citation>Feinman RD, Pogozelski WK, Astrup A, et al. . Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition. 2015;31:1–13. Erratum in: Nutrition. 2019 Jun;62:213.</Citation><ArticleIdList><ArticleId IdType="pubmed">25287761</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly B, Pearce EL. Amino assets: how amino acids support immunity. Cell Metab. 2020;32:154–75.</Citation><ArticleIdList><ArticleId IdType="pubmed">32649859</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyajima M. Amino acids: key sources for immunometabolites and immunotransmitters. Int Immunol. 2020;32:435–46.</Citation><ArticleIdList><ArticleId IdType="pubmed">32383454</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>